How to Navigate Ecosystem Connect NEWDistinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats
SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy
Description:
This study is being performed to establish the association between absorbed dose to tumor and response and absorbed dose to normal organs and toxicity following Lu177-PSMA radioligand therapy
Sponsor:
University of Michigan Rogel Cancer Center
Contacts:
James Pooljampool@med.umich.edu
734-615-7391
Government Study Link:
NCT07096999 - Click here to see study onClinicalTrials.gov
Lu177-PSMA-617
Isotope(s):
Target(s):
- PSMA
Ligand: Small Molecules
Chelator: DOTA
